Skip to main content
. 2021 Sep 29;9(2):e00391-21. doi: 10.1128/Spectrum.00391-21

Appendix 3E.

COVID-19 related characteristics of participants who had a previously PCR-confirmed infection and their test results on Abbott SARS-CoV-2 IgG

Parameter All participants
Test result
Grayzone
Positive
Negative
n % n % n % n %
Total 367 93 150 124
Close contact with a case of COVID-19
 Yes 211 57.5 56 60.2 90 60.0 65 52.4
 No 154 42.0 37 39.8 58 38.7 59 47.6
 Unknown 2 0.5 0 0.0 2 1.3 0 0.0
Main type of patient contacta
 Daily contact with known/suspected COVID-19 patients 88 24.0 22 23.7 40 26.7 26 21.0
 Daily contact with patients without COVID-19 218 59.4 56 60.2 88 58.7 74 59.7
 No patient contact 61 16.6 15 16.1 22 14.7 24 19.4
Symptoms at time of previous PCR test
 No symptoms 7 1.9 1 1.1 3 2.0 3 2.4
 Had symptoms 358 97.5 92 98.9 145 96.7 121 97.6
 Unknown 2 0.5 0 0.0 2 1.3 0 0.0
Severity of symptoms
 Minor symptoms 151 41.1 38 43.2 51 35.2 62 51.2
 Significant symptoms 178 48.5 48 54.5 75 51.7 55 45.5
 Severe symptoms (hospitalized) 29 7.9 6 6.8 19 13.1 4 3.3
No. of mo since positive PCR test
 Less than 1 8 2.2 1 1.1 6 4.0 1 0.8
 1 8 2.2 0 0.0 8 5.3 0 0.0
 2 4 1.1 0 0.0 4 2.7 0 0.0
 3 1 0.3 0 0.0 1 0.7 0 0.0
 4 12 3.3 2 2.2 10 6.7 0 0.0
 5 85 23.2 28 30.1 34 22.7 23 18.5
 6 222 60.5 54 58.1 77 51.3 91 73.4
 7 25 6.8 8 8.6 8 5.3 9 7.3
 Unknown 2 0.5 0 0.0 2 1.3 0 0.0
No. of mo since onset of symptomsb
 Less than 1 5 1.5 1 1.1 3 2.2 1 0.9
 1 8 2.4 0 0.0 8 5.8 0 0.0
 2 3 0.9 0 0.0 3 2.2 0 0.0
 3 1 0.3 0 0.0 1 0.7 0 0.0
 4 12 3.5 2 2.3 10 7.2 0 0.0
 5 78 22.9 25 28.4 32 23.2 21 18.4
 6 210 61.8 52 59.1 73 52.9 85 74.6
 7 23 6.8 8 9.1 8 5.8 7 6.1
a

Participants were asked which one describes most of their current work.

b

Excludes 27 participants who were not symptomatic at the time of their positive PCR test.